{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:41:51Z","timestamp":1769107311615,"version":"3.49.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["CS\/17\/3\/32799"],"award-info":[{"award-number":["CS\/17\/3\/32799"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>None of the existing studies on adherence have directly measured levels of\u00a0all medications (or their metabolites) in patients with heart failure (HF).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>We used liquid chromatography\u2013tandem mass spectrometry to measure the presence of prescribed drugs (diuretics, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, beta-blockers, and mineralocorticoid receptor antagonists) in the urine of patients reviewed 4\u20136\u2009weeks after hospitalization with HF. Patients were unaware that adherence was being assessed. Of the 341 patients studied, 281 (82.4%) were adherent, i.e. had all prescribed drugs of interest detectable in their urine. Conversely, 60 patients (17.6%) were partially or completely non-adherent. Notably, 24 of the 60 were non-adherent to only diuretic therapy and only seven out of all 341 patients studied (2.1%) were completely non-adherent to all prescribed HF drugs. There were no major differences in baseline characteristics between adherent and non-adherent patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Non-adherence, assessed using a single spot urine measurement of drug levels, was confirmed in one of five patients evaluated 4\u20136\u2009weeks after hospitalization with HF.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjcvp\/pvaa071","type":"journal-article","created":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T19:13:27Z","timestamp":1592766807000},"page":"296-301","source":"Crossref","is-referenced-by-count":18,"title":["Adherence to prescribed medications in patients with heart failure: insights from liquid chromatography\u2013tandem mass spectrometry-based urine analysis"],"prefix":"10.1093","volume":"7","author":[{"given":"Joanne","family":"Simpson","sequence":"first","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences, University of Glasgow, British Heart Foundation Glasgow Cardiovascular Research Centre, 126 University Place, Glasgow G12 8TA, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colette E","family":"Jackson","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences, University of Glasgow, British Heart Foundation Glasgow Cardiovascular Research Centre, 126 University Place, Glasgow G12 8TA, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Haig","sequence":"additional","affiliation":[{"name":"Robertson Centre for Biostatistics, Boyd Orr Building, University of Glasgow, Glasgow G12 8QQ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4306-5317","authenticated-orcid":false,"given":"Pardeep S","family":"Jhund","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences, University of Glasgow, British Heart Foundation Glasgow Cardiovascular Research Centre, 126 University Place, Glasgow G12 8TA, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8215-6567","authenticated-orcid":false,"given":"Maciej","family":"Tomaszewski","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, AV Hill Building, Upper Brook Street, Manchester M13 9PT, UK"},{"name":"Division of Medicine, Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy S","family":"Gardner","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences, University of Glasgow, British Heart Foundation Glasgow Cardiovascular Research Centre, 126 University Place, Glasgow G12 8TA, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yannis","family":"Tsorlalis","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences, University of Glasgow, British Heart Foundation Glasgow Cardiovascular Research Centre, 126 University Place, Glasgow G12 8TA, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6333-9496","authenticated-orcid":false,"given":"Mark C","family":"Petrie","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences, University of Glasgow, British Heart Foundation Glasgow Cardiovascular Research Centre, 126 University Place, Glasgow G12 8TA, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J V","family":"McMurray","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences, University of Glasgow, British Heart Foundation Glasgow Cardiovascular Research Centre, 126 University Place, Glasgow G12 8TA, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iain B","family":"Squire","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, University of Leicester, NIHR Biomedical Research Centre, Glenfield Hospital, Groby Road, Leicester LE3 9QP, UK"},{"name":"National Institute of Health Research Leicester Biomedical Research Unit in Cardiovascular Disease,\u00a0Glenfield Hospital, Groby Road, Leicester LE3 9QP, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, University of Leicester, NIHR Biomedical Research Centre, Glenfield Hospital, Groby Road, Leicester LE3 9QP, UK"},{"name":"Department of Chemical Pathology, University Hospitals of Leicester NHS Trust, Sandringham Building, Leicester Royal Infirmary, Infirmary Square, Leicester LE1 5WW, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,6,29]]},"reference":[{"key":"2021072618093558800_pvaa071-B1","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(05)67760-4","article-title":"Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial","volume":"366","author":"Granger","year":"2005","journal-title":"Lancet"},{"key":"2021072618093558800_pvaa071-B2","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1001\/archinte.1988.00380090087021","article-title":"Precipitating factors leading to decompensation of heart failure. Traits among urban blacks","volume":"148","author":"Ghali","year":"1988","journal-title":"Arch Intern Med"},{"key":"2021072618093558800_pvaa071-B3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10741-012-9321-3","article-title":"Determinants of adherence to heart failure medication: a systematic literature review","volume":"18","author":"Oosterom-Calo","year":"2013","journal-title":"Heart Fail Rev"},{"key":"2021072618093558800_pvaa071-B4","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1001\/archinte.165.18.2069","article-title":"The complexity and cost of drug regimens of older patients hospitalized with heart failure in the United States, 1998-2001","volume":"165","author":"Masoudi","year":"2005","journal-title":"Arch Intern Med"},{"key":"2021072618093558800_pvaa071-B5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11906-016-0697-7","article-title":"How to screen for non-adherence to antihypertensive therapy","volume":"18","author":"Gupta","year":"2016","journal-title":"Curr Hypertens Rep"},{"key":"2021072618093558800_pvaa071-B6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cardfail.2007.11.005","article-title":"Objectively measured, but not self-reported, medication adherence independently predicts event-free survival in patients with heart failure","volume":"14","author":"Wu","year":"2008","journal-title":"J Card Fail"},{"key":"2021072618093558800_pvaa071-B7","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.0889-7204.2002.01643.x","article-title":"Adherence to angiotensin-converting enzyme inhibitor therapy for heart failure","volume":"17","author":"Bohachick","year":"2002","journal-title":"Prog Cardiovasc Nurs"},{"key":"2021072618093558800_pvaa071-B8","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1592\/phco.23.3.326.32112","article-title":"Association between adherence to diuretic therapy and health care utilization in patients with heart failure","volume":"23","author":"Chui","year":"2003","journal-title":"Pharmacotherapy"},{"key":"2021072618093558800_pvaa071-B9","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1161\/CIRCULATIONAHA.106.669101","article-title":"Persistent use of evidence-based pharmacotherapy in heart failure is associated with improved outcomes","volume":"116","author":"Gislason","year":"2007","journal-title":"Circulation"},{"key":"2021072618093558800_pvaa071-B10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/eurjhf\/hfq015","article-title":"Adherence to the medical regime in patients with heart failure","volume":"12","author":"Muzzarelli","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"2021072618093558800_pvaa071-B11","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1136\/heartjnl-2013-305063","article-title":"High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS\/MS) urine analysis","volume":"100","author":"Tomaszewski","year":"2014","journal-title":"Heart"},{"key":"2021072618093558800_pvaa071-B12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/eurjhf\/hfq015","article-title":"Adherence to the medical regime in patients with heart failure","volume":"12","author":"Muzzarelli","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"2021072618093558800_pvaa071-B13","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/eurjhf\/hft085","article-title":"Spectral microvolt T-wave alternans testing has no prognostic value in patients recently hospitalized with decompensated heart failure","volume":"15","author":"Jackson","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2021072618093558800_pvaa071-B14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/eurjhf\/hfs010","article-title":"Profile of microvolt T-wave alternans testing in 1003 patients hospitalized with heart failure","volume":"14","author":"Jackson","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2021072618093558800_pvaa071-B15","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2021072618093558800_pvaa071-B16","volume-title":"Clarke's Analysis of Drugs and Poisons","author":"Moffat","year":"2011","edition":"4th ed"},{"key":"2021072618093558800_pvaa071-B17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.14712\/18059694.2019.46","article-title":"The assessment of serum drug levels to diagnose non-adherence in stable chronic heart failure patients","volume":"62","author":"Pelouch","year":"2019","journal-title":"Acta Medica (Hradec Kralove)"},{"key":"2021072618093558800_pvaa071-B18","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/ejhf.493","article-title":"Non-adherence to ivabradine and placebo and outcomes in chronic heart failure: an analysis from SHIFT","volume":"18","author":"B\u00f6hm","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2021072618093558800_pvaa071-B19","first-page":"1018","article-title":"Medication adherence to specific drug classes in chronic heart failure","volume":"20","author":"Viana","year":"2014","journal-title":"J Manag Care Spec Pharm"},{"key":"2021072618093558800_pvaa071-B20","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ijcard.2015.03.042","article-title":"Age-related medication adherence in patients with chronic heart failure: a systematic literature review","volume":"184","author":"Krueger","year":"2015","journal-title":"Int J Cardiol"},{"key":"2021072618093558800_pvaa071-B21","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1161\/HYPERTENSIONAHA.116.08729","article-title":"Risk factors for nonadherence to antihypertensive treatment","volume":"69","author":"Gupta","year":"2017","journal-title":"Hypertension"},{"key":"2021072618093558800_pvaa071-B22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1080\/08037051.2019.1599814","article-title":"Adherence to antihypertensive drug treatment in patients with apparently treatment-resistant hypertension in the INSPiRED pilot study","volume":"28","author":"Wunder","year":"2019","journal-title":"Blood Press"},{"key":"2021072618093558800_pvaa071-B23","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1161\/CIRCULATIONAHA.107.706820","article-title":"Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction","volume":"117","author":"Jackevicius","year":"2008","journal-title":"Circulation"},{"key":"2021072618093558800_pvaa071-B24","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s10557-004-6225-z","article-title":"Self-reported adherence to cholesterol-lowering medication in patients with familial hypercholesterolaemia: the role of illness perceptions","volume":"18","author":"Senior","year":"2004","journal-title":"Cardiovasc Drugs Ther"},{"key":"2021072618093558800_pvaa071-B25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.hrtlng.2012.08.003","article-title":"Frequency of urinary incontinence in people with chronic heart failure","volume":"42","author":"Hwang","year":"2013","journal-title":"Heart Lung"}],"container-title":["European Heart Journal - Cardiovascular Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ehjcvp\/advance-article-pdf\/doi\/10.1093\/ehjcvp\/pvaa071\/33882560\/pvaa071.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ehjcvp\/article-pdf\/7\/4\/296\/39317024\/pvaa071.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ehjcvp\/article-pdf\/7\/4\/296\/39317024\/pvaa071.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T18:10:08Z","timestamp":1627323008000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article\/7\/4\/296\/5864720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,29]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,6,29]]},"published-print":{"date-parts":[[2021,7,23]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcvp\/pvaa071","relation":{},"ISSN":["2055-6837","2055-6845"],"issn-type":[{"value":"2055-6837","type":"print"},{"value":"2055-6845","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,7,1]]},"published":{"date-parts":[[2020,6,29]]}}}